Arizona Sues L'Oreal, Alleging Concealment of Hair Relaxer Cancer Risks

The state of Arizona has filed a lawsuit against L'Oreal SA, alleging the global cosmetics giant knowingly concealed evidence that its chemical hair relaxer products could increase the risk of cancer in women. This marks the first time a U.S. state has taken legal action against the company over this issue, amplifying the legal challenges L'Oreal faces.

Details of the Lawsuit

Filed in Arizona state court by Attorney General Kristin Mayes, the lawsuit accuses L'Oreal of violating state consumer protection laws. It alleges the company marketed its products, which are predominantly used by African American women, for decades without warning consumers of potential links to ovarian and uterine cancers.

The state is seeking financial penalties and damages. It also requests a court order that would compel L'Oreal to cease selling the products in Arizona unless it adds a clear warning about the associated cancer risks. The complaint argues that L'Oreal "exploited centuries of social pressures and discriminatory beauty standards" for financial gain while disregarding consumer safety.

Broader Legal Context

This state-level action follows a wave of private litigation against L'Oreal and other cosmetics manufacturers, including Revlon. L'Oreal is already defending itself against more than 12,000 similar lawsuits from individuals and their families. These cases have been consolidated into a multidistrict litigation (MDL) in a Chicago federal court to streamline proceedings.

Ad

The surge in lawsuits began after the release of a landmark 2022 study by the National Institutes of Health (NIH). The study found that women who frequently used chemical hair straightening products were more than twice as likely to develop uterine cancer compared to those who did not.

Company Position and Market Impact

L'Oreal has consistently maintained that its products are safe and that the claims against them lack legal or scientific merit. In previous statements regarding the MDL, the company has said its products are subject to rigorous safety reviews. A spokesperson for L'Oreal did not immediately respond to a request for comment on the new Arizona lawsuit, according to Reuters.

The lawsuit from a state attorney general adds a significant new dimension to L'Oreal's legal exposure. Unlike individual claims, a state-led lawsuit can carry different legal weight and resources, potentially creating a precedent for other states to follow. The ongoing litigation represents a material risk for the company, with potential for significant financial liabilities and reputational damage.